GlobalData on MSN
Crystalys Therapeutics begins Phase III trials for gout treatment
The multi-centre, randomised, double-blind RUBY and TOPAZ studies are assessing the therapy’s performance against allopurinol ...
Urica Therapeutics, a majority-owned subsidiary of Fortress, reported that Crystalys Therapeutics has dosed the first ...
These Phase 3 clinical studies are designed to evaluate the safety and efficacy of dotinurad compared to an active control ...
GlobalData on MSN
Arthrosi gains $153m for development of gout therapy
US-based biotechnology company Arthrosi Therapeutics has completed a series E funding round, amassing $153m which is ...
Gout is the most common type of inflammatory arthritis. Eating foods like red meat, alcohol, and shellfish make the symptoms ...
The company is one of a handful developing a more “selective” URAT1 inhibitor, an approach that’s seen as a way to improve ...
Gout is a type of inflammatory arthritis. It occurs when your blood has a buildup of uric acid. This acid causes crystals to form in a joint, which leads to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback